5 commercial payer policies list 86617. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
5 policies from 5 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of 86617 |
|---|---|---|
| Myalgic Encephalomyelitis - Chronic Fatigue Syndrome (ME/CSF) | Jun 21, 2023 | Covered |
| Policy | Effective | Status of 86617 |
|---|---|---|
| Intravenous Antibiotic Therapy and Associated Diagnostic Testing for Lyme Disease | Dec 15, 2025 | Covered |
| Policy | Effective | Status of 86617 |
|---|---|---|
| Intravenous Antibiotic Therapy and Associated Diagnostic Testing for Lyme Disease | Dec 15, 2025 | Covered |
| Policy | Effective | Status of 86617 |
|---|---|---|
| Intravenous Antibiotic Therapy and Associated Diagnostic Testing for Lyme Disease | Dec 15, 2025 | Covered |
| Policy | Effective | Status of 86617 |
|---|---|---|
| Intravenous Antibiotic Therapy and Associated Diagnostic Testing for Lyme Disease | Dec 15, 2025 | Covered |